Mitiglinide calcium hydrate

Mitiglinide calcium hydrate (S-21403 calcium hydrate) is a drug for the treatment of type 2 diabetes. Mitiglinide is thought to stimulate insulin secretion by closing the ATP-sensitive K(+) K(ATP) channels in pancreatic beta-cells. Mitiglinide belongs to the meglitinide class of blood glucose-lowering drugs and is currently co-marketed in Japan by Kissei and Takeda.

Price Not Available 100 mg Mitiglinide calcium hydrate Supplier Page

Catalog Number	T1530
Alternative Name(s)	Mitiglinide calcium , S-21403 calcium hydrate , KAD-1229 calcium hydrate
Research Area	Membrane transporter/Ion channel
Molecular Formula	C38H52CaN2O8
CAS#	207844-01-7
SMILES	[Ca+2].C(=O)([C@H](CC(=O)N1C[C@@H]2[C@H](C1)CCCC2)Cc1ccccc1)[O-].O.C(=O)([C@H](CC(=O)N1C[C@@H]2[C@H](C1)CCCC2)Cc1ccccc1)[O-].O
Size	100 mg
Supplier Page	https://www.targetmol.com/compound/Mitiglinide calcium hydrate
Additional Information	https://www.targetmol.com/datasheet/T1530